Diabettech AI

In this episode, our hosts take a deep dive into the Nine Sensor Samba, an n=1 experiment that pits a variety of newly released CGM systems against the incumbents, Dexcom and Libre. With 9 sensors, 15 days and 150 fingerpricks, the outcomes aren't quite what you're expecting!

In this episode, our hosts discuss the review of Snaq undertaken over at Diabettech, noting the benefits and frustrations of using it, and the conclusions the reviewer drew. The two articles this is drawn from are: https://www.diabettech.com/ai/snaq-a-diabetes-ai-to-help-you-carb-count-badly/ https://www.diabettech.com/diabetes/beyond-snaq-qing-digesting-your-glucose-patterns/

In this episode, our hosts discuss the attempts that LLMs made to analyse a series of images describing outcomes and pump settings, highlighting the benefits and issues that arose in the experiment. Suffice to say that it wasn't all sweetness and light and they won't be replacing healthcare professionals just yet.

Our hosts discuss how Large Language Models manage when presented with images of foods to analyse and determine the carb content. It turns out that they are about as good as humans...

In this episode, the twins discuss the study that Diabettech undertook to see how the various AI models handled facts, tips, etc. There's obviously no irony in this approach...

Our AI hosts discuss the outline of a study comparing how well AI systems give diabetes advice.

With all the information demonstrating that Incretins appears to shield against heart problems, our hosts discuss whether they could help alleviate the complications of diabetes.

A discussion focusing on Medtronic spinning out its Diabetes division, and with Ypsomed doing the same, what it means for the Diabetes Devices industry...

Our favourite hosts discussing the advantages and disadvantages of the "more accurate" and "more data" CGMs on the market at the moment and draw some interesting conclusions. Discussion generated by Google Gemini AI.

In this episode, Mac and Lin discuss infusion site locations and the potential effects on AID systems of changing between abdomen, arms and thighs. it's worth noting that they haven't quite understood that the predominant study referred to in the article used a rapid acting insulin rather than regular human insulin to arrive at the numbers provided. Original article at: https://wp.me/p7O2EL-2uK

In this episode, Mac and Lin discuss the challenges of managing exercise with automated insulin delivery systems. https://www.diabettech.com/insulin/exercise-insulin-and-automation-the-challenges/

In this episode, we discover that Lin also has type 1 and Mac and Lin discuss the head to head study between the Abbott Libre3 and Dexcom G7 study published in the Journal of Diabetes Science and Technology in March and highlight some of the challenges with it. https://www.diabettech.com/cgm/welcome-to-the-wild-wild-west-the-cgm-head-to-head-study/

This episode discusses the findings a small study looking at incretin-based therapy used by people with type 1 diabetes who are also using Open Source Automated delivery systems.

In this episode, Mac and Lin dig into the pharmacokinetics of incretins and how they might affect glucose management in type 1 diabetes. Original Source: https://wp.me/p7O2EL-2t0

This episode discusses a couple of posts on diabettech.com that dive into the data derived from CGM, pump and smart watch and offers some ideas on how that might help with diabetes management. Sources: https://www.diabettech.com/biological-data/diabetes-and-data-what-more-can-we-learn-part-1/ https://www.diabettech.com/biological-data/diabetes-and-data-what-more-can-we-learn-part-2/

This episode looks at Loop and AndroidAPS, published studies on their performance and a study on pigs that compared the algorithms and discussed why options are important and how these open source solutions are safe. Source Data at: https://pubmed.ncbi.nlm.nih.gov/33226840/ https://www.nejm.org/doi/full/10.1056/NEJMoa2203913 https://www.diabettech.com/artificial-pancreas/automated-insulin-delivery...

A look at the differences between the types of pump and some of the non-obvious reasons why you might want to choose one or the other. To note: Google's AI wasn't quite aware of what tunneling is... https://www.diabettech.com/patch-pump/to-patch-pump-or-not-to-patch-pump-that-is-the-question/

This episode features a discussion on GLP1-RAs, what they do physiologically and how they might affect Type 1 Diabetes.